Estrogen receptor and programmed death ligand-1 expression in type 1 endometrial cancer and its associated clinicopathological characteristics
Background: This study aimed to determine the association of estrogen receptor (ER) and programmed death ligand-1 (PD-L1) expression with the clinicopathological characteristics of type 1 endometrial cancer. Materials and methods: A total of 85 patients with type 1 endometrial cancer who underwent s...
Main Authors: | Setyo Teguh Waluyo, Brahmana Askandar Tjokroprawiro, Anny Setijo Rahaju |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Cancer Treatment and Research Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468294223000886 |
Similar Items
-
Correlation between estrogen receptor and programmed death ligand-1 in type I endometrial cancer
by: Setyo Teguh Waluyo, et al.
Published: (2024-03-01) -
PD-L1 Expression in Endometrial Cancer and Its Association with Clinicopathological Features: A Systematic Review and Meta-Analysis
by: Mohd Nazzary Mamat @ Yusof, et al.
Published: (2022-08-01) -
Clinical Implication of PD-L1 Expression in Patients with Endometrial Cancer
by: Yeorae Kim, et al.
Published: (2023-10-01) -
Endometrial Cancer with and without Endometriosis: Clinicopathological Differences
by: Takahiro Minamikawa, et al.
Published: (2023-11-01) -
Role of Estrogen Receptor β, G-Protein Coupled Estrogen Receptor and Estrogen-Related Receptors in Endometrial and Ovarian Cancer
by: Susanne Schüler-Toprak, et al.
Published: (2023-05-01)